Express Scripts' price fluctuations reflect market dynamics, with shares surging on news of a potential Cigna takeover worth $67 billion. Investors are closely watching Chanos' bet against Mallinckrodt and Express Scripts. August 2013 saw a potential buy point for ESRX, highlighting the company's potential for growth.